Voloridge Investment Management, LLC Y M Abs Therapeutics, Inc. Transaction History

Voloridge Investment Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$25.45 - $37.64 $330,544 - $488,868	-12,988 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$29.16 - $51.96 $378,730 - $674,856	12,988 New	12,988 $393,000
Q3 2020 Nov 16, 2020	SELL	$35.13 - $43.62 $553,754 - $687,582	-15,763 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$23.66 - $49.53 $372,952 - $780,741	15,763 New	15,763 $681,000
Q1 2020 May 15, 2020	SELL	$14.39 - $35.8 $393,480 - $978,915	-27,344 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$23.81 - $33.78 $651,060 - $923,680	27,344 New	27,344 $855,000

106

24.5M

40.3K

400

Ticker YMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,719,500
Market Cap $487M
Description
Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Voloridge Investment Management, LLC with notifications on news.